Clarus Group Inc. Sells 919 Shares of UnitedHealth Group Incorporated $UNH

Clarus Group Inc. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 49.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 942 shares of the healthcare conglomerate’s stock after selling 919 shares during the period. Clarus Group Inc.’s holdings in UnitedHealth Group were worth $294,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Financial Management Professionals Inc. grew its position in shares of UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after buying an additional 17 shares during the last quarter. Global Wealth Strategies & Associates boosted its position in shares of UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after purchasing an additional 20 shares in the last quarter. Retirement Planning Group LLC boosted its position in shares of UnitedHealth Group by 5.1% during the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after purchasing an additional 21 shares in the last quarter. Net Worth Advisory Group boosted its position in shares of UnitedHealth Group by 0.6% during the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after purchasing an additional 21 shares in the last quarter. Finally, Bensler LLC boosted its holdings in UnitedHealth Group by 0.3% in the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock worth $3,637,000 after acquiring an additional 22 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.2%

NYSE UNH opened at $351.87 on Thursday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market cap of $318.68 billion, a PE ratio of 15.25, a price-to-earnings-growth ratio of 2.27 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a 50-day moving average of $298.81 and a 200-day moving average of $362.32.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 EPS. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 38.30%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Sanford C. Bernstein increased their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Piper Sandler decreased their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. JPMorgan Chase & Co. dropped their price target on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 6th. Finally, Bank of America raised their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a report on Monday, August 18th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.